Within the spectrum subtypes of metastatic breast cancer, hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2-) breast cancer emerges as a prevalent type with a poor prognosis [2]. Here, ERBB2 is linked to breast carcinoma.